Screening assays

Details for Australian Patent Application No. 2005210006 (hide)

Owner Novartis AG

Inventors Jaritz, Markus; Hackermueller, Joerg; Meisner, Nicole-Claudia; Auer, Manfred

Agent Davies Collison Cave

Pub. Number AU-B-2005210006

PCT Pub. Number WO2005/075637

Priority 60/542,315 05.02.04 US; 60/560,464 08.04.04 US

Filing date 4 February 2005

Wipo publication date 18 August 2005

Acceptance publication date 25 September 2008

International Classifications

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

27 July 2006 PCT application entered the National Phase

  PCT publication WO2005/075637 Priority application(s): WO2005/075637

25 September 2008 Application Accepted

  Published as AU-B-2005210006

22 January 2009 Standard Patent Sealed

2 September 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005210014-Compositions containing cis-isomers of a carotenoid compound and process

2005210004-Novel inhibitors of glutaminyl cyclase